In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 245 for your search:
Drug:  lomustine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9802, E-R9802, NCCTG-R9802, SWOG-R9802, RTOG-DEV-1012, NCT00003375, RTOG-98-02

2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: EORTC-LAM-4

3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-86-C-92A, NCI-NMOB-855, NCI-T86-0137N, T86-0137

4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 16
Sponsor:
Protocol IDs: EORTC-26921

5.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: MRC-BR03, EU-94010

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9404, NCCTG-947251, SWOG-9340, RTOG-94-04

7.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9402, CAN-NCIC-CE2, E-R9402, NCCTG-927252, SWOG-9402, INT-0149, NCT00002569, CE2

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: MRC-LU03, EU-94018

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: MRC-LU04, EU-94019

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 70
Sponsor:
Protocol IDs: MSHMC-REN-2

11.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 69
Sponsor: Other
Protocol IDs: EORTC-26951, MRC-BR11, NCT00002840

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 3 to 21 at diagnosis
Sponsor: NCI
Protocol IDs: CCG-A9961, POG-A9961, NCT00002875, A9961

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Under 10
Sponsor: NCI
Protocol IDs: COG-A9952, CCG-A9952, POG-A9952, CCG-9952, A9952, NCT00002944

14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: RHG-MM97, EU-98030, NCT00003603

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: HEALTHONE-43892, HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788

16.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-9813, ECOG-R9813, NCCTG-RTOG-9813, RTOG-98-13, NCT00004259

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: CHNMC-COH-CA-LUN-1, NCI-D80-035-131

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7701

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7312A

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WCG-119

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: WCG-120

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor:
Protocol IDs: WCG-130

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 75
Sponsor:
Protocol IDs: WFU-62277

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 20
Sponsor: NCI
Protocol IDs: CCG-243

25.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 16
Sponsor: NCI
Protocol IDs: CLB-7751
1     
New Search